BioCentury
ARTICLE | Clinical News

BioCancell preclinical data

February 7, 2011 8:00 AM UTC

In a mouse model of glioblastoma, BC-821 significantly reduced tumor growth by 60% compared to untreated controls. BC-821 is a plasmid that activates the synthesis of diphtheria toxin in cancer cells ...